NICE and its value judgments: Option of safe “understudy” treatments should be availableBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7468.740 (Published 23 September 2004) Cite this as: BMJ 2004;329:740
- Woody Caan, professor of public health (email@example.com)
- APU, Chelmsford, Essex CM1 1SQ
EDITOR—The National Institute for Clinical Excellence (NICE) aims for the highest attainable standards of care.1 The bedrock of its advice is published evidence of benefits from treatment (mainly pharmaceuticals).
In the report accepted in May consideration of safety issues focused on invasive surgical and diagnostic procedures, and the “judgment” on risk assumed that such risks are small and …